Caroline Sköld
PhD student at Department of Surgical Sciences; Orthopaedics and Handsurgery
- E-mail:
- caroline.skold@uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 61, 6 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 61, 6 tr
751 85 UPPSALA
Publications
Recent publications
Is 18F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?
Part of Clinical Orthopaedics and Related Research, p. 415-428, 2025
- DOI for Is 18F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?
- Download full text (pdf) of Is 18F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?
Part of Osteoporosis International, p. 1-8, 2022
- DOI for Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.
- Download full text (pdf) of Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.
All publications
Articles in journal
Is 18F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?
Part of Clinical Orthopaedics and Related Research, p. 415-428, 2025
- DOI for Is 18F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?
- Download full text (pdf) of Is 18F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?
Part of Osteoporosis International, p. 1-8, 2022
- DOI for Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.
- Download full text (pdf) of Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.